As has been indicated earlier, we do actively enforce the Consumer Packaging and Labelling Act and regulations on the basis of guidelines, so continuing to do that in this scenario is indeed possible. As Mr. Mayers has pointed out, it is also possible to move ahead with the regulatory framework associated with consumer protection issues under the Consumer Packaging and Labelling Act as well as under the Food and Drugs Act and regulations.
When we use guidelines, even though it's not a regulatory process, we still follow sound regulatory policy when we look at changing guidelines. That includes assessing whether it is indeed responding to the objective that has been identified and what the impacts will be. So we still evaluate what the impacts would be on industry, taking into account our trade obligations and the other aspects that we take into account when we do a regulatory amendment.
As with any change, there can be some additional costs for industry as they change formulations or change labelling to respond to a new labelling policy. With regard to additional costs for CFIA to enforce, there are current guidelines that we enforce. Changing those guidelines is not likely to add additional enforcement costs. What it does is change the priority, because when we introduce a new requirement, that increases the priority of our enforcement of that particular provision. With any new requirement, whether that be through the guidelines or through regulation, communication is absolutely key. Communicating those new requirements is a very core provision with any amendment.